Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C24H27N.C6H12O7 |
| Molecular Weight | 525.6332 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 4 / 5 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.CC(CC1=CC=CC=C1)NCCC(C2=CC=CC=C2)C3=CC=CC=C3
InChI
InChIKey=XWLQOHKWSBPMOX-IFWQJVLJSA-N
InChI=1S/C24H27N.C6H12O7/c1-20(19-21-11-5-2-6-12-21)25-18-17-24(22-13-7-3-8-14-22)23-15-9-4-10-16-23;7-1-2(8)3(9)4(10)5(11)6(12)13/h2-16,20,24-25H,17-19H2,1H3;2-5,7-11H,1H2,(H,12,13)/t;2-,3-,4+,5-/m.1/s1
| Molecular Formula | C24H27N |
| Molecular Weight | 329.4779 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
| Molecular Formula | C6H12O7 |
| Molecular Weight | 196.1553 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 4 / 4 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Refining the human iPSC-cardiomyocyte arrhythmic risk assessment model. | 2013-12 |
|
| Comparative evaluation of HERG currents and QT intervals following challenge with suspected torsadogenic and nontorsadogenic drugs. | 2006-03 |
|
| [Modulation of serine/threonine protein kinase activity in chloramphenicol-resistant mutants of Streptomyces avermitilis]. | 2004-08-03 |
|
| Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs. | 1993-12-01 |
|
| Prevention of adriamycin-induced cardiotoxicity by prenylamine: a pilot double blind study. | 1987 |
|
| Atrio-ventricular block after administration of lignocaine in patients treated with prenylamine. | 1982-03 |
|
| An overall review on prenylamine mechanisms of action in experimental models of myocardial damage. | 1982 |
|
| Overdrive pacing in quinidine syncope and other long QT-interval syndromes. | 1980-08 |
|
| Protective effect of creatinol O-phosphate (COP) on ventricular fibrillation and death induced by intravenous CaCl2 in mice. | 1979 |
|
| [Prevention of isoproterenol-induced lesions in the rat myocardium by prenylamine]. | 1975-09-01 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 11:38:25 GMT 2025
by
admin
on
Wed Apr 02 11:38:25 GMT 2025
|
| Record UNII |
Q09085O516
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
167965
Created by
admin on Wed Apr 02 11:38:25 GMT 2025 , Edited by admin on Wed Apr 02 11:38:25 GMT 2025
|
PRIMARY | |||
|
Q09085O516
Created by
admin on Wed Apr 02 11:38:25 GMT 2025 , Edited by admin on Wed Apr 02 11:38:25 GMT 2025
|
PRIMARY | |||
|
21156-48-9
Created by
admin on Wed Apr 02 11:38:25 GMT 2025 , Edited by admin on Wed Apr 02 11:38:25 GMT 2025
|
PRIMARY | |||
|
DTXSID10943479
Created by
admin on Wed Apr 02 11:38:25 GMT 2025 , Edited by admin on Wed Apr 02 11:38:25 GMT 2025
|
PRIMARY |